Find Your Balance

IncrexxaTM (tulathromycin injection)

Increxxa contains tulathromycin, the same macrolide antibiotic veterinarians and the cattle industry have depended on to control and treat bovine respiratory disease (BRD) in cattle for more than 15 years. It’s a go-to antibiotic for beef and dairy producers because of its one-time use, extended duration of action, ease of administration and broad-spectrum control.

image its all about balance cow doing handstand

Control and Treat BRD With Lasting Confidence

BRD is a complex respiratory disease in cattle that costs producers across the industry an average of $3 billion annually.1,2,3 It can be brought on by a variety of physical and physiological stressors. These include weaning, age, undernutrition, parasitism, handling, dust, acidosis, commingling, transportation, time, weather and vaccination status, which make it incredibly difficult to control and lead to death.

Balance your BRD protocol and budget with Increxxa, which combines the proven performance of tulathromycin with quality manufacturing from Elanco. With Increxxa, producers and veterinarians get a macrolide antibiotic they depend on at a better value. It’s also labeled for the treatment of pinkeye and footrot, giving them one more reason to choose it as a cattle health solution.

icon chevron

Fast Acting*

Quickly targets site of infection in lungs and circulates rapidly for early BRD control.4

icon hourglass

Long Half-Life*

Gives more time to bolster an effective defense.4

icon bar graph increasing

Supports Profitability

Reduces return trips to the hospital pen and gets healthy cattle back to the feedbunk.4

icon shield

Consistent Quality

Manufactured with Elanco’s uncompromising standard for potency, uniformity and quality.

* Clinical relevance unknown.

* Clinical relevance unknown.

photo 2 cattlemen in herd of cattle

Important Product Information 

Learn more about how to properly administer, store and use Increxxa. See label for complete use guidelines, including all cautions and warnings. Always read, understand and follow the label and use directions.


Beef: Treatment of BRD and control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis. Treatment of infectious bovine keratoconjunctivitis associated with Moraxella bovis. Treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.

Suckling calves, dairy calves and veal calves: Treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Haemophilus somni and Mycoplasma bovis.

photo beef cattle feeding

1 Johnson K., Pendell D., 2017, “Market impacts of reducing the prevalence of bovine respiratory disease in United States beef cattle feedlots.” Front Vet Sci.;2071(4):189-97.

2 Griffin D. 1997, “Economic impact associated with respiratory disease in beef cattle.” Vet Clin North Am Food Anim Pract.;13(3):367-77.

3 USDA. 2015, “Cattle and Calves Death Loss in the United States Due to Predator and Nonpredator Causes, 2015.” USDA-APHIS-VS-CEAH. Fort Collins, CO #745.1217

4 Villarino N., Brown S., Martin-Jimenez T. 2014, “Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.” Vet Pharmacol Ther.;37(3):211-21.

About Elanco

FarmAnimal products

Learn why we're a leading provider of innovative solutions that protect and enhance animal health.

Read About Elanco

Connect with Elanco

Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. ©2022 Elanco or its affiliates.

Increxxa is a trademark of Elanco. ©2021 Elanco. PM-US-21-0267